NHS funding cleared for new specialised treatments
Three new specialised treatments are now to be made available on the NHS for patients in England after being initially rejected for funding back in December, NHS England has announced.
Read More
Tag: C3 glomerulopathy
- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
